Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Targeting Caspase 8: Using Structural and Ligand-Based Approaches to Identify Potential Leads for the Treatment of Multi-Neurodegenerative Diseases.

Ahmad K, Balaramnavar VM, Chaturvedi N, Khan S, Haque S, Lee YH, Choi I.

Molecules. 2019 May 12;24(9). pii: E1827. doi: 10.3390/molecules24091827.

2.

Aegeline inspired synthesis of novel β3-AR agonist improves insulin sensitivity in vitro and in vivo models of insulin resistance.

Rajan S, Satish S, Shankar K, Pandeti S, Varshney S, Srivastava A, Kumar D, Gupta A, Gupta S, Choudhary R, Balaramnavar VM, Narender T, Gaikwad AN.

Metabolism. 2018 Aug;85:1-13. doi: 10.1016/j.metabol.2018.03.001. Epub 2018 Mar 8.

PMID:
29524448
3.

Aegeline inspired synthesis of novel amino alcohol and thiazolidinedione hybrids with antiadipogenic activity in 3T3-L1 cells.

Satish S, Srivastava A, Yadav P, Varshney S, Choudhary R, Balaramnavar VM, Narender T, Gaikwad AN.

Eur J Med Chem. 2018 Jan 1;143:780-791. doi: 10.1016/j.ejmech.2017.11.041. Epub 2017 Nov 26.

PMID:
29220798
4.

Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport.

Gupta A, Singh VK, Kumar D, Yadav P, Kumar S, Beg M, Shankar K, Varshney S, Rajan S, Srivastava A, Choudhary R, Balaramnavar VM, Bhatta R, Tadigoppula N, Gaikwad AN.

Metabolism. 2017 Aug;73:109-124. doi: 10.1016/j.metabol.2017.05.005. Epub 2017 May 20.

PMID:
28732567
5.

Design, synthesis and evaluation of benzofuran-acetamide scaffold as potential anticonvulsant agent.

Shakya AK, Kamal M, Balaramnavar VM, Bardaweel SK, Naik RR, Saxena AK, Siddiqui HH.

Acta Pharm. 2016 Sep 1;66(3):353-72. doi: 10.1515/acph-2016-0023.

PMID:
27383885
6.

Designing, synthesis of selective and high-affinity chalcone-benzothiazole hybrids as Brugia malayi thymidylate kinase inhibitors: In vitro validation and docking studies.

Sashidhara KV, Avula SR, Doharey PK, Singh LR, Balaramnavar VM, Gupta J, Misra-Bhattacharya S, Rathaur S, Saxena AK, Saxena JK.

Eur J Med Chem. 2015 Oct 20;103:418-28. doi: 10.1016/j.ejmech.2015.09.004. Epub 2015 Sep 8.

PMID:
26383126
7.

Homology modeling and virtual screening of inhibitors against TEM- and SHV-type-resistant mutants: A multilayer filtering approach.

Baig MH, Balaramnavar VM, Wadhwa G, Khan AU.

Biotechnol Appl Biochem. 2015 Sep-Oct;62(5):669-80. doi: 10.1002/bab.1370. Epub 2015 Jul 2.

PMID:
25779642
8.

Identification of potent caspase-3 inhibitors for treatment of multi- neurodegenerative diseases using pharmacophore modeling and docking approaches.

Ahmad K, Balaramnavar VM, Baig MH, Srivastava AK, Khan S, Kamal MA.

CNS Neurol Disord Drug Targets. 2014;13(8):1346-53.

PMID:
25345515
9.

Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking.

Balaramnavar VM, Srivastava R, Rahuja N, Gupta S, Rawat AK, Varshney S, Chandasana H, Chhonker YS, Doharey PK, Kumar S, Gautam S, Srivastava SP, Bhatta RS, Saxena JK, Gaikwad AN, Srivastava AK, Saxena AK.

Eur J Med Chem. 2014 Nov 24;87:578-94. doi: 10.1016/j.ejmech.2014.09.097. Epub 2014 Oct 2.

PMID:
25299681
10.

Identification of novel phenyl butenonyl C-glycosides with ureidyl and sulfonamidyl moieties as antimalarial agents.

Ramakrishna KK, Gunjan S, Shukla AK, Pasam VR, Balaramnavar VM, Sharma A, Jaiswal S, Lal J, Tripathi R, Anubhooti, Ramachandran R, Tripathi RP.

ACS Med Chem Lett. 2014 Jun 2;5(8):878-83. doi: 10.1021/ml500211c. eCollection 2014 Aug 14.

11.

Pharmacokinetic and metabolism studies of rohitukine in rats by high performance liquid-chromatography with tandem mass spectrometry.

Chhonker YS, Chandasana H, Kumar D, Mishra SK, Srivastava S, Balaramnavar VM, Gaikwad AN, Kanojiya S, Saxena AK, Bhatta RS.

Fitoterapia. 2014 Sep;97:34-42. doi: 10.1016/j.fitote.2014.05.004. Epub 2014 May 16.

PMID:
24840406
12.

Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo.

Varshney S, Shankar K, Beg M, Balaramnavar VM, Mishra SK, Jagdale P, Srivastava S, Chhonker YS, Lakshmi V, Chaudhari BP, Bhatta RS, Saxena AK, Gaikwad AN.

J Lipid Res. 2014 Jun;55(6):1019-32. doi: 10.1194/jlr.M039925. Epub 2014 Mar 19.

13.

Molecular cloning and characterization of Brugia malayi thymidylate kinase.

Doharey PK, Suthar MK, Verma A, Kumar V, Yadav S, Balaramnavar VM, Rathaur S, Saxena AK, Siddiqi MI, Saxena JK.

Acta Trop. 2014 May;133:83-92. doi: 10.1016/j.actatropica.2014.02.003. Epub 2014 Feb 17.

PMID:
24556140
14.

Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.

Saxena A, Balaramnavar VM, Hohlfeld T, Saxena AK.

Eur J Pharmacol. 2013 Dec 5;721(1-3):215-24. doi: 10.1016/j.ejphar.2013.09.032. Epub 2013 Sep 25.

PMID:
24075938
15.

Antidyslipidemic and antioxidant effects of novel Lupeol-derived chalcones.

Srivastava S, Sonkar R, Mishra SK, Tiwari A, Balaramnavar VM, Mir S, Bhatia G, Saxena AK, Lakshmi V.

Lipids. 2013 Oct;48(10):1017-27. doi: 10.1007/s11745-013-3824-0. Epub 2013 Aug 14. Erratum in: Lipids. 2013 Dec;48(12):1297. Balramnavar, Vishal [corrected to Balaramnavar, Vishal M].

PMID:
23943005
16.

Identification of novel 2-((1-(benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)benzoic acid analogues as BMP-2 stimulators.

Balaramnavar VM, Khan IA, Siddiqui JA, Khan MP, Chakravarti B, Sharan K, Swarnkar G, Rastogi N, Siddiqui HH, Mishra DP, Chattopadhyay N, Saxena AK.

J Med Chem. 2012 Oct 11;55(19):8248-59. doi: 10.1021/jm300985d. Epub 2012 Oct 3.

PMID:
22978808

Supplemental Content

Loading ...
Support Center